Management of neurologic disorders.
Ciavarella
D
D
New York Blood Center, New York Medical College, Valhalla.
Wuest
D
D
Strauss
R G
RG
Gilcher
R O
RO
Kasprisin
D O
DO
Kiprov
D D
DD
Klein
H G
HG
McLeod
B C
BC
D014150:Antipsychotic Agents / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000188:drug therapy / Q000628:therapy; D003131:Combined Modality Therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D009422:Nervous System Diseases / Q000188:drug therapy / Q000628:therapy*; D009468:Neuromuscular Diseases / Q000628:therapy; D010257:Paraneoplastic Syndromes / Q000628:therapy; D010951:Plasma Exchange; D011618:Psychotic Disorders / Q000188:drug therapy / Q000628:therapy
D014150:Antipsychotic Agents; D007166:Immunosuppressive Agents